[Recent advances and trends in the therapies for benign prostatic hyperplasia].
A number of new treatment modalities for benign prostatic hyperplasia (BPH) have been introduced in these days: for example, laser ablation, alpha-adrenergic blocker, antiandrogens, hyperthermia, stenting and balloon dilation. The author basically mentioned the personal experiences in some of these modalities, and gave a general review on their effectiveness and safety. Also pointed out were a variety of problems, important but sometimes ignored, in the evaluation of treatments for BPH, including severity grading of BPH, response criteria of effectiveness, method for proper selection of treatment.
Homma
Y
Y
Department of Urology, University of Tokyo.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000627:therapeutic use; D002404:Catheterization; D006801:Humans; D006979:Hyperthermia, Induced; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000628:therapy*; D015607:Stents
D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists